PD1&PDL1 Inhibitors
Market
PD1&PDL1 Inhibitors Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
PD1&PDL1
Inhibitors Market Size and Growth
The PD-1 and PD-L1 inhibitors market is experiencing robust growth, driven by increasing cancer prevalence and advancements in immunotherapy. Valued at approximately $30 billion in 2023, the market is expected to expand significantly over the coming years, supported by ongoing research and development initiatives and a diverse pipeline of therapies. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Bristol-Myers Squibb
◍ Merck
◍ Roche
◍ Pfizer
◍ AstraZeneca
◍ Ono Pharmaceutical
The PD-1/PD-L1 inhibitors market features key players like Bristol-Myers Squibb, Merck, Roche, Pfizer, AstraZeneca, and Ono Pharmaceutical, driving growth through innovative treatments and expanding indications. Notable sales revenues include:
- Bristol-Myers Squibb: ~$7.8 billion (Opdivo)
- Merck: ~$14.4 billion (Keytruda)
- Roche: ~$9.3 billion (Tecentriq)
Request Sample Report
Market Segmentation
By Application
◍ Hospital Pharmacies
◍ Retail Pharmacies
◍ Online Pharmacies
By Product
◍ PD1 Inhibitors
◍ PDL1 Inhibitors
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
